Total depression and subtypes in prostate cancer survivors 10 years after treatment

Trajectories of total depression and depressive symptoms in prostate cancer patients receiving six months of hormone therapy

(2016) Christopher F. Sharpley et al.   PSYCHO-ONCOLOGY

Cancer-related symptoms predict psychological wellbeing among prostate cancer survivors: results from the PiCTure study

(2015) Linda Sharp et al.   PSYCHO-ONCOLOGY

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial

(2014) James W Denham et al.   LANCET ONCOLOGY

Differences in major depressive disorder and generalised anxiety disorder symptomatology between prostate cancer patients receiving hormone therapy and those who are not

(2014) Christopher F. Sharpley et al.   PSYCHO-ONCOLOGY

Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates

(2014) Sam Watts et al.   BMJ Open

Differences in neurobiological pathways of four “clinical content” subtypes of depression

(2013) Christopher F. Sharpley et al.   BEHAVIOURAL BRAIN RESEARCH

Validity, reliability and prevalence of four ‘clinical content’ subtypes of depression

(2013) Christopher F. Sharpley et al.   BEHAVIOURAL BRAIN RESEARCH

The incidence and causes of different subtypes of depression in prostate cancer patients: implications for cancer care

(2013) C.F. Sharpley et al.   EUROPEAN JOURNAL OF CANCER CARE

Are Somatic Symptoms a Legitimate Part of the Depression Profile in Prostate Cancer Patients?

(2013) Christopher F. Sharpley et al.   ONKOLOGIE

Quality of life and functional outcomes 10 years after laparoscopic radical prostatectomy

(2013) Eugen Y-H. Wang et al.   UPSALA JOURNAL OF MEDICAL SCIENCES

The Trajectory of Depressive Symptoms Across the Adult Life Span

(2013) Angelina R. Sutin et al.   JAMA Psychiatry

A Novel Approach for Developing and Interpreting Treatment Moderator Profiles in Randomized Clinical Trials

(2013) Meredith L. Wallace et al.   JAMA Psychiatry

Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial

(2012) James W Denham et al.   LANCET ONCOLOGY

Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial

(2011) James W Denham et al.   LANCET ONCOLOGY

The burden of depression in prostate cancer

(2011) Ravishankar Jayadevappa et al.   PSYCHO-ONCOLOGY

Levels of anxiety and depression as predictors of mortality: the HUNT study

(2009) Arnstein Mykletun et al.   BRITISH JOURNAL OF PSYCHIATRY

Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors

(2008) Martin G. Sanda et al.   NEW ENGLAND JOURNAL OF MEDICINE

Understanding the causes of depression among prostate cancer patients: development of the effects of prostate cancer on lifestyle questionnaire

(2008) Christopher F. Sharpley et al.   PSYCHO-ONCOLOGY